FMX-101

DRUG3 trials

Sponsors

Vyne Therapeutics Inc.

Conditions

Healthy

Phase 1

A Randomized, Controlled Study to Evaluate the Sensitizing Potential of FMX-101 in Healthy Volunteers Using a Repeat Insult Patch Test Design

CompletedNCT04052711

Vyne Therapeutics Inc.Healthy

Start: 2016-09-08End: 2016-12-19Updated: 2019-08-21

Dermal Cumulative Irritant Patch Study

CompletedNCT04064125

Vyne Therapeutics Inc.Healthy

Start: 2016-09-01End: 2016-10-28Updated: 2019-08-28

Dermal Photo Allergic Skin Reaction

CompletedNCT04070755

Vyne Therapeutics Inc.Healthy

Start: 2016-09-21End: 2016-12-18Updated: 2019-08-28